The following table sets forth the total compensation awarded to, earned by and paid during the fiscal year ended December 31, 2023 for each of our named executive officers. The following table also presents information regarding the compensation awarded to, and earned by, and paid to each such individual during the fiscal year ended December 31, 2022, to the extent such individual was a named executive officer for such year.
| Name and Principal Position | Year | Salary($) | StockAwards($)(1) | OptionAwards($)(2) | Non-EquityIncentiveCompensation($)(3) | All OtherCompensation($)(4) | Total ($) |
|---|
| Diana Brainard (5) | 2023 | 623,432 | 2,211,125 | 3,209,186 | — | 13,200 | 6,056,943 |
|---|
| Chief Executive Officer | 2022 | 604,992 | 3,899,006 | 4,327,381 | 361,800 | 12,200 | 9,205,379 |
|---|
| Vikas Sinha (5) | 2023 | 373,042 | 1,047,375 | 1,520,252 | — | — | 2,940,669 |
|---|
| President and Chief Financial Officer | 2022 | 369,007 | 1,386,290 | 981,658 | 162,454 | 4,753 | 2,904,162 |
|---|
| Edward Miller | 2023 | 448,458 | 581,875 | 844,337 | — | 13,200 | 1,887,870 |
|---|
| General Counsel and Secretary | 2022 | 433,992 | 393,312 | 467,589 | 173,597 | 10,805 | 1,479,295 |
|---|
| (1) | The amount reported represents the aggregate grant date fair value of the restricted stock units, or RSUs, awarded to the named executive officers during 2023 and 2022, calculated in accordance with Financial Accounting Standards Board, or FASB, Accounting Standards Codification, or ASC, Topic 718. Such grant date fair value does not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the restricted stock and RSUs reported in this column are set forth in Note 2 to our audited consolidated financial statements in our Annual Report on Form 10-K filed with the SEC on March 15, 2024. The amount reported in this column reflects the accounting cost for these RSU awards and does not correspond to the actual economic value that may be received by the named executive officers upon the vesting or settlement of the RSUs or any sale of the shares. |
| (2) | The amounts reported represent the aggregate grant date fair value of the stock options granted to such named executive officers during 2023 and 2022 as computed in accordance with FASB ASC Topic 718, not including any estimates of forfeitures related to service-based vesting conditions. The assumptions used in calculating the grant date fair value of the options reported in this column are set forth in Note 2 to our audited consolidated financial statements in our Annual Report on Form 10-K filed with the SEC on March 15, 2024. |
| (3) | Amounts reported reflect the annual cash incentive bonus paid based upon achievement of certain corporate performance objectives described below under “Annual Cash Incentive Bonuses.” |
| (4) | The amounts reported represent matching contributions made by the Company under its 401(k) plan. |
| (5) | Dr. Brainard and Mr. Sinha also serve as members of our Board but do not receive any additional compensation for their service as director. |
